{"abstract": "The list of doubters about Eli Lilly\u2018s $6.5 billion deal to buy ImClone Systems, the biotechnology company controlled by Carl C. Icahn, is growing.", "web_url": "https://dealbook.nytimes.com/2008/10/10/doubts-grow-over-lillys-imclone-deal/", "snippet": "", "lead_paragraph": "The list of doubters about Eli Lilly\u2018s $6.5 billion deal to buy ImClone Systems, the biotechnology company controlled by Carl C. Icahn, is growing.", "source": "The New York Times", "multimedia": [], "headline": {"main": "Doubts Grow Over Lilly\u2019s ImClone Deal", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [], "pub_date": "2008-10-10T11:08:55+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Dealbook", "person": [{"firstname": "Dealbook", "middlename": null, "lastname": "", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/183dcfe5-034b-52c3-b5e3-a69c23f27126", "word_count": 236, "uri": "nyt://article/183dcfe5-034b-52c3-b5e3-a69c23f27126"}